Professor Giuseppe Kito Fusai
MS, FRCS
Consultant Hepato-Pancreato-Biliary (HPB) Surgeon
After qualifying at the University of Milan in 1987 and obtaining a Master of Surgery from the University of Parma in 1992, I moved to the UK in 1995 and in 1996 I became a Fellow of the Royal College of Surgeons of Edinburgh.
Since then, I worked and trained in several centres of excellence for the treatment of HPB conditions, including Nagoya University Hospital, very well known for the management of hilar cholangiocarcinoma.
I have practiced this type of surgery for over thirty years and I have been a HPB Consultant Surgeon since 2008, performing more nearly 2000 major HPB surgeries with a perioperative mortality of 1,7% well below the National and International standards for both liver and pancreatic surgery.
Current NHS Post: Royal Free Hospital – HPB & Liver Transplant Unit
Current Leadership position(s):
- Past President of Italian Medical Society of Great Britain
- Chair of HPB Surgery
Personal profile:
I am married with two children. I have a charity called Fiorina, for the treatment and research on Pancreatic Cancer, which has supported several projects over the last 12 years. I am a past President of the Italian Medical Society.
Hospital Locations
Royal Free Hospital
Languages spoken
English, Italian
Specialities
- General Surgery
- HPB surgery
- Neuroendocrine Tumours (NETs)
Memberships
- BMA
- AUGIS
- ASGBI
- E-AHPBA and IHPBA
- ESA
- ISGPS
Registration and licensing
GMC:4147143
Procedures offered
- Biliary reconstruction
- Decompressive pancreatic surgery for chronic pancreatitis
- Distal and total pancreatectomy
- Laparoscopic cholecystectomy (gallbladder removal)
- Liver resection (hepatectomy)
- Liver transplant surgery
- Whipple pancreato-duodenectomy
- Vascular reconstruction
Clinical interests
- Cholangiocarcinoma (Bile duct cancer)
- HPB surgery
- Liver cancer and metastases
- Liver transplants
- Neuroendocrine tumours (NETs)
- Pancreatic cancer
- Second opinions - approximately 1 in 5 patients operated comes from second opinions provided for patients deemed inoperable in other centres
Research interests
Over the last few years I have been part and led several international multicentre projects, including the “arterial study for patients with locally advanced pancreatic cancer” and “Orange II plus” a randomised controlled trial comparing laparoscopic versus open hemi-hepatectomy.